Glutamine

World Review of Nutrition and Dietetics

Volumn 105, Issue , 2013, Pages 90-96

  Kim, Mike ^a   Wischmeyer, Paul E ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMINE;

CRANIOCEREBRAL TRAUMA; CRITICAL ILLNESS; DOSE RESPONSE; ENTERIC FEEDING; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; INTENSIVE CARE UNIT; PARENTERAL NUTRITION; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME;

CRANIOCEREBRAL TRAUMA; CRITICAL ILLNESS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENTERAL NUTRITION; GLUTAMINE; HUMANS; HYPERGLYCEMIA; INSULIN RESISTANCE; INTENSIVE CARE UNITS; PARENTERAL NUTRITION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84870483455     PISSN: 00842230     EISSN: 16623975     Source Type: Book Series    
DOI: 10.1159/000341276     Document Type: Article

References (34)

1. Gamrin L, Essen P, Forsberg AM, Hultman E, Wernerman J: A descriptive study of skeletal muscle metabolism in critically ill patients: free amino acids, energy-rich phosphates, protein, nucleic acids, fat, water, and electrolytes. Crit Care Med 1996; 24:575-583. (Pubitemid 26133789)
2. Newsholme EA, Crabtree B, Ardawi MS: Glutamine metabolism in lymphocytes: its biochemical, physiological and clinical importance. Q J Exp Physiol 1985; 70:473-489. (Pubitemid 16255147)
3. Wilmore DW: The effect of glutamine supplementation in patients following elective surgery and accidental injury. J Nutr 2001; 131(9 Suppl):2543S-2549S, discussion 2550S-2541S. (Pubitemid 32847007)
4. Oudemans-van Straaten HM, Bosman RJ, Treskes M, van der Spoel HJ, Zandstra DF: Plasma glutamine depletion and patient outcome in acute ICU admissions. Intensive Care Med 2001; 27:84-90. (Pubitemid 32208973)
5. Wischmeyer PE: Glutamine: role in critical illness and ongoing clinical trials. Curr Opin Gastroenterol 2008; 24:190-197. (Pubitemid 351322786)
6. Coeffier M, Dechelotte P: The role of glutamine in intensive care unit patients: mechanisms of action and clinical outcome. Nutr Rev 2005; 63:65-69. (Pubitemid 40250745)
7. Preiser JC, Wernerman J: Glutamine, a life-saving nutrient, but why? Crit Care Med 2003; 31: 2555-2556. (Pubitemid 37281745)
8. Curi R, Newsholme P, Procopio J, Lagranha C, Gorjao R, Pithon-Curi TC: Glutamine, gene expression, and cell function. Front Biosci 2007; 12: 344-357. (Pubitemid 46852844)
9. Wischmeyer PE: Glutamine and heat shock protein expression. Nutrition 2002; 18:225-228. (Pubitemid 34204132)
10. Morrison AL, Dinges M, Singleton KD, Odoms K, Wong HR, Wischmeyer PE: Glutamine's protection against cellular injury is dependent on heat shock factor-1. Am J Physiol Cell Physiol 2006; 290: C1625-C1632. (Pubitemid 43830803)
11. Wischmeyer PE: Glutamine: the first clinically relevant pharmacological regulator of heat shock protein expression? Curr Opin Clin Nutr Metab Care 2006; 9:201-206. (Pubitemid 44097829)
12. Pelham HR: Speculations on the functions of the major heat shock and glucose-regulated proteins. Cell 1986; 46:959-961. (Pubitemid 17182721)
13. Weitzel LR, Mayles WJ, Sandoval PA, Wischmeyer PE: Effects of pharmaconutrients on cellular dysfunction and the microcirculation in critical illness. Curr Opin Anaesthesiol 2009; 22:177-183.
14. Weiss YG, Bouwman A, Gehan B, Schears G, Raj N, Deutschman CS: Cecal ligation and double puncture impairs heat shock protein 70 (HSP-70) expression in the lungs of rats. Shock 2000; 13:19-23.
15. Singleton KD, Serkova N, Beckey VE, Wischmeyer PE: Glutamine attenuates lung injury and improves survival after sepsis: role of enhanced heat shock protein expression. Crit Care Med 2005; 33: 1206-1213. (Pubitemid 40827366)
16. Wischmeyer PE, Musch M W, Madonna MB, Thisted R, Chang EB: Glutamine protects intestinal epithelial cells: role of inducible HSP70. Am J Physiol 1997; 272:G879-G884.
17. Ziegler TR, Ogden LG, Singleton KD, et al: Parenteral glutamine increases serum heat shock protein 70 in critically ill patients. Intensive Care Med 2005; 31:1079-1086. (Pubitemid 41125339)
18. Lappas GD, Karl IE, Hotchkiss RS: Effect of ethanol and sodium arsenite on HSP-72 formation and on survival in a murine endotoxin model. Shock 1994; 2:34-39, discussion 40.
19. Villar J, Edelson JD, Post M, Mullen JB, Slutsky AS: Induction of heat stress proteins is associated with decreased mortality in an animal model of acute lung injury. Am Rev Respir Dis 1993; 147:177-181. (Pubitemid 23025936)
20. Chu EK, Ribeiro S P, Slutsky AS: Heat stress increases survival rates in lipopolysaccharide-stimulated rats. Crit Care Med 1997; 25:1727-1732. (Pubitemid 27435511)
21. Singleton KD, Beckey VE, Wischmeyer PE: Glutamine prevents activation of NF-kappaB and stress kinase pathways, attenuates inflammatory cytokine release, and prevents acute respiratory distress syndrome (ARDS) following sepsis. Shock 2005; 24:583-589.
22. Roth E: Nonnutritive effects of glutamine. J Nutr 2008; 138:2025S-2031S.
23. Dechelotte P, Hasselmann M, Cynober L, et al: L-alanyl - L-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: the French controlled, randomized, double-blind, multicenter study. Crit Care Med 2006; 34:598-604.
24. Bakalar B, Duska F, Pachl J, et al: Parenterally administered dipeptide alanyl-glutamine prevents worsening of insulin sensitivity in multiple-trauma patients. Crit Care Med 2006; 34:381-386. (Pubitemid 43145616)
25. Novak F, Heyland DK, Avenell A, Drover J W, Su X: Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med 2002; 30:2022-2029.
26. Andrews PJ, Avenell A, Noble D W, et al: Randomised trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients. BMJ 2011; 342:d1542.
27. Wernerman J, Kirketeig T, Andersson B, et al: Scandinavian glutamine trial: a pragmatic multicentre randomised clinical trial of intensive care unit patients. Acta Anaesthesiol Scand 2011; 55:812-818.
28. Grau T, Bonet A, Minambres E, et al: The effect of L-alanyl - L-glutamine dipeptide supplemented total parenteral nutrition on infectious morbidity and insulin sensitivity in critically ill patients. Crit Care Med 2011; 39:1263-1268.
29. Yang DL, Xu JF: Effect of dipeptide of glutamine and alanine on severe traumatic brain injury. Clin J Traumatol 2007:145-149.
30. Berg A, Bellander BM, Wanecek M, et al: Intravenous glutamine supplementation to head trauma patients leaves cerebral glutamate concentration unaffected. Intensive Care Med 2006; 32:1741-1746. (Pubitemid 44607361)
31. Berg A, Bellander BM, Wanecek M, et al: The pattern of amino acid exchange across the brain is unaffected by intravenous glutamine supplementation in head trauma patients. Clin Nutr 2008; 27: 816-821.
32. Heyland DK, Dhaliwalm R, Day A, et al: Optimizing the dose of glutamine dipeptides and anitoxidants in critically ill patients: a phase I dose-finding study. JPEN J Parenter Enteral Nutr 2007; 31:109-118.
33. McClave SA, Martindale RG, Vanek VW, et al: Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr 2009; 33:277-316.
34. Singer P, Berger MM, Van den Berghe G, et al: ESPEN guidelines on parenteral nutrition: intensive care. Clin Nutr 2009; 28:387-400.